Overview

AstraZeneca Pty Limited is a Proprietary Company that is ranked number 392 out of the top 2000 companies in Australia. The company generates the majority of its income from the Pharmaceutical Product Manufacturing in Australia industry.

In 2015 the company generated total revenue of $1,093,637,000 including sales and other revenue. In 2015 AstraZeneca Pty Limited had 720 employees in Australia including employees from all subsidiaries under the company's control.

The Chief Executive of AstraZeneca Pty Limited is Mr Paul Spittle whose official title is Country President Australia & New Zealand. The Chairman of AstraZeneca Pty Limited is either not applicable or not available. 

The group manufactures and sells pharmaceuticals in the following areas:

  • Anaesthesia & Pain Management - Brands include Citanest, Diprivan, Emla, Fetanyl Injection, Marcain, Naropin, Pethidine, Xylocaine and Xyloproct.
  • Cardiovascular and Diabetes - Products used for the treatment of diabetes and for diseases relating to the structure and function of the heart and blood vessels, such as heart failure and high cholesterol. Brands include Atacand, Betaloc and Zestri amongst many others.
  • Gastrointestinal - Products used for the gastrointestinal organs relating diseases. Brands include Acimax, Entocort, Losec, Nexium and Omrepral.
  • Neuroscience - Products used for ailments relating to the structure and function of the brain such as migraine headaches and schizophrenia. Brands include Inderal, Seroquel, Xylocard and Zomig.
  • Oncology -Products used for the treatment of cancer include Iressa, Zoladex and Nolvadex amongst others.
  • Respiratory - Products used for the treatment of asthma & rhinitis include Bricanyl, Rhinocort and Symbicort amongst others.
  • Hospital & Infection - Brands include Neostigmine, Zinforo and Pancuronium Injection BP amongst others.

 

 

Learn more about our Company Reports

IBISWorld Premium Company Reports

The IBISWorld Company Premium Report offers a wealth of information on the top 550 companies. The detailed information and analysis in the Premium Report help you become better informed on all company activities. IBISWorld Company Premium Reports include:

  • Cross Directorships
  • Company activities synopsis
  • Industry Ratios
  • More segment information
  • Competitive Environment analysis
  • Subsidiaries by region

Table of Contents

Company Details
Key Personnel
Financials
Segments
Growth & Ratios
Industry Averages
Competitive Environment
Shareholders
Subsidiaries
Service Providers

Looking for our Industry reports?

Assess your competitors with powerful business tools that provide strategic insights and analysis on over 600 Australian industries.

Contact Us

Want to speak to a representative? Call us.

clear